Dna X SONM Cash Flow Statement (2018-2026)

NASDAQ SONM
$3.24 +0.02 (+0.68%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Dna X Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

Dna X reported cash from operations of -$5.47M and free cash flow of -$5.56M for the quarter ended Jun 2026, down 12.0% year over year. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-10.94M-11.74M-7.21M-4.22M-1.61M-1.19M0.23M0.51M0.53M-0.93M-2.91M-6.62M-2.51M8.91M0.33M-7.61M-4.75M3.45M6.34M5.09M
Share-based Compensation
0.28M1.98M-0.59M0.22M0.64M0.41M5.73M5.84M4.95M0.46M5.16M0.73M0.74M-3.04M0.72M0.93M0.69M0.16M0.30M0.40M
Deferred Taxes
-0.00M-0.03M0.16M0.60M1.36M
Gains from Investment Securities
Asset Writedowns and Impairment
0.73M0.91M0.00M0.00M3.22M3.27M0.98M
Cash from Operations
-5.70M-17.56M-0.61M0.77M-10.29M-2.22M-4.22M0.82M-0.30M-0.35M-0.17M-3.39M-0.42M-4.51M-9.61M-4.88M-7.03M-2.00M-3.47M-5.47M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.14M0.12M0.17M-0.03M0.06M0.07M0.06M
Amortization of Deferred Charges
0.04M0.04M
Depreciation & Amortization (CF)Depreciation & Amortization
0.59M0.50M0.19M0.20M0.17M1.82M0.63M0.55M0.07M0.96M0.88M0.84M0.92M0.91M1.05M0.80M0.95M1.50M0.13M
Change in Working Capital
Change in Receivables
-2.78M8.19M-0.38M-5.11M10.97M6.15M2.60M1.54M3.77M-4.88M-6.48M0.61M-2.72M1.22M0.65M-1.98M0.63M1.81M-0.25M-0.25M
Change in Inventory
-1.98M-2.74M-0.32M-1.80M0.67M-0.18M0.60M0.23M-0.52M2.30M-1.69M-0.00M8.56M-1.88M-2.25M1.27M0.97M-3.83M
Change in Account Payables
-3.76M-3.03M3.97M-5.31M4.30M8.69M-0.52M0.31M2.34M-3.41M0.54M0.09M-0.11M13.79M-5.55M3.29M-0.17M11.97M-2.65M-2.67M
Change in Accured Expenses
2.23M-0.33M0.32M0.52M-1.28M0.08M-2.14M0.77M1.12M1.61M-0.40M1.47M9.77M-2.83M-0.22M-1.22M1.41M-1.93M-1.29M-2.01M
Change in Taxes
0.01M0.13M0.03M0.04M-0.05M0.00M0.01M0.02M0.07M0.04M-0.06M0.11M0.09M0.10M-0.04M0.06M0.78M-0.22M-0.47M
Other Working Capital Changes
-0.55M-1.03M-2.29M0.16M-1.28M-0.63M-0.14M-0.30M0.09M-0.07M-0.04M1.44M-0.76M2.31M0.13M0.46M-1.40M-1.30M-1.66M-1.51M
Investing Activities
Capital Expenditures
0.03M0.00M0.00M0.00M0.00M0.01M0.03M0.04M0.14M0.01M0.09M
Cash from Investing Activities
-0.03M-0.00M-0.00M-0.00M-0.00M-0.01M-0.03M-0.04M-0.14M-0.01M3.36M3.26M
Financing Activities
Other financing activities
0.02M0.05M-0.01M
Debt Issuance and Repayment
Long-Term Debt Issuances
2.79M2.32M1.26M1.80M
Long-Term Debt Repayments
0.04M0.04M0.04M0.04M-0.04M0.04M0.04M
Short-Term Debt issuances
-0.04M0.04M0.04M0.04M0.05M-0.64M1.18M-1.15M
Change in Capital Stock
Net Shares Issued and Repurchased
0.02M0.00M4.41M1.25M0.18M0.04M0.01M0.04M0.01M0.01M0.03M
Net Equity Issued and Repurchased
18.66M0.04M14.37M0.00M0.11M0.21M3.54M4.50M4.84M-0.13M
Misc.
Cash from Financing Activities
9.01M18.64M0.01M6.76M7.61M-0.04M-0.04M-0.04M0.38M-0.04M0.05M3.78M0.01M0.80M6.38M4.77M7.17M1.17M1.80M
Change in Cash
3.29M1.05M-0.60M7.53M-2.68M-2.26M-4.25M0.76M0.08M-0.40M-0.14M0.35M-0.54M-3.72M-3.23M-0.11M0.13M-0.83M-0.11M-0.40M
Free Cash Flow
-5.70M-17.59M-0.61M0.76M-10.29M-2.23M-4.22M0.82M-0.30M-0.36M-0.20M-3.43M-0.55M-4.52M-9.61M-4.88M-7.03M-2.00M-3.47M-5.56M
Net Cash Flow
3.31M1.05M-0.60M7.53M-2.68M-2.26M-4.25M0.78M0.08M-0.40M-0.14M0.35M-0.54M-3.72M-3.23M-0.11M0.13M-0.83M-0.11M-0.40M